Patents by Inventor Kanna NAGAISHI

Kanna NAGAISHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HYDROGEL STRUCTURE, METHOD FOR PRODUCING HYDROGEL STRUCTURE, AGENT, AND TRANSPLANTATION METHOD
    Publication number: 20230381375
    Abstract: Provided is a novel structure containing mesenchymal stem cells that can be used in various applications. A hydrogel fiber (10) comprises a hydrogel (14) that contains mesenchymal stem cells.
    Type: Application
    Filed: October 29, 2021
    Publication date: November 30, 2023
    Applicants: CellFiber Co., Ltd., SAPPORO MEDICAL UNIVERSITY
    Inventors: Kanna NAGAISHI, Kazuhiro IKEDA
  • Activator for mesenchymal stem cells, activated mesenchymal stem cells, and method for producing same
    Patent number: 10512660
    Abstract: [Problem] To activate an abnormal mesenchymal stem cell whose therapeutic effect is lost or reduced, or rather which has a disease-exacerbating effect so as to be in a state suitable for cell transplant therapy. [Solution] An activator for mesenchymal stem cells, mesenchymal stem cells activated by the activator, a method for producing the same, and a pharmaceutical containing the activated mesenchymal stem cells are provided.
    Type: Grant
    Filed: March 11, 2015
    Date of Patent: December 24, 2019
    Assignee: Sapporo Medical University
    Inventors: Mineko Fujimiya, Kanna Nagaishi, Yuka Mizue, Takako Chikenji
  • ACTIVATOR FOR MESENCHYMAL STEM CELLS, ACTIVATED MESENCHYMAL STEM CELLS, AND METHOD FOR PRODUCING SAME
    Publication number: 20170071984
    Abstract: [Problem] To activate an abnormal mesenchymal stem cell whose therapeutic effect is lost or reduced, or rather which has a disease-exacerbating effect so as to be in a state suitable for cell transplant therapy. [Solution] An activator for mesenchymal stem cells, mesenchymal stem cells activated by the activator, a method for producing the same, and a pharmaceutical containing the activated mesenchymal stem cells are provided.
    Type: Application
    Filed: March 11, 2015
    Publication date: March 16, 2017
    Applicant: Sapporo Medical University
    Inventors: Mineko FUJIMIYA, Kanna NAGAISHI, Yuka MIZUE, Takako CHIKENJI